1. Modern Strategies for Insulin Use in Today's Type 2 Diabetes Treatment Era

2. Short-, Intermediate-, Long-Acting Insulins

3. Clinical Practice Assessment Question

4. Role of Insulin U-500 in Patients With Extreme Insulin Resistance

5. Insulin Glargine U-300 Less Nocturnal Hypoglycemia vs U-100

6. Insulin Degludec* An Ultra-Long-Acting Basal Insulin Analog

7. Clinical Practice Assessment Question

8. On the Horizon: Biosimilar Insulins First Biosimilar Insulin Glargine

9. Insulin Peglispro/BIL* A Novel, Polyethylene Glycolylated Insulin

10. Clinical Practice Assessment Question

11. Abbreviations

12. References

13. References (cont)

14. References (cont)